Tags: buprenorphineopioidMARrelapseoverdose
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Meagan Parrish Pharma Voice Senior editor @industrydive.
Pharma world follower. Wisconsin, USA | ||
| 2 | Rick Lange, MD, Texas Tech; Elizabeth Tracey MedPage Today Texas Tech University System, advancing higher education and health care. Lubbock, Texas | ||
| 3 | Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois | More evidence on GLP-1s and opioid addiction - 28 days ago Eli Lilly gets FDA approval to sell Mounjaro as obesity drug called Zepbound - about 1 year ago | |
| 4 | Emily Olsen Healthcare Dive Reporter at Healthcare Dive. Loyola, Medill alum. Chicago, Illinois | ||
| 5 | MedPage Today Staff MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | Which GLP-1 Drug Was Tied to a Signal of Suicidal Thoughts? - 3 months ago | |
| 6 | Kathleen Kenny, PharmD, RPh Pharmacy Times Postdoc researcher. Reproductive justice advocate. Toronto, Ontario | Safe Opioid Prescribing, Storage Are Crucial - 3 months ago | |
| 7 | Shannon Firth MedPage Today Washington correspondent for MedPageToday. CUNYJschool pride. | No Survival Benefit to Higher Intranasal Naloxone Dose - 9 months ago Adding Nurse Care Managers in Primary Care Boosted OUD Treatment - about 1 year ago | |
| 8 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | ||
| 9 | Michael DePeau-Wilson MedPage Today Enterprise Reporter. AI in Healthcare focus. Journalism alum. Not specified | ||
| 10 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey |